Are you looking for big returns for your ASX share portfolio? If you are, then read on because the ASX 300 shares in this article are being tipped to rise strongly from current levels by analysts at Morgans.
Here's what the broker is saying about these ASX 300 shares:
Image source: Getty Images
Nanosonics Ltd (ASX: NAN)
Morgans remains positive on this infection control specialist and sees a lot of value in its shares.
The broker recently put a buy rating and $5.00 price target on them. Based on its current share price of $4.09, this implies potential upside of 22% for investors.
Its analysts believe the ASX 300 share is well-positioned for long term growth thanks to its strong core business and the launch of the new CORIS product. It explains:
We have updated our forecasts following a deeper review of guidance provided and management commentary, particularly around tariff impacts and CORIS commercialisation timing. While near-term earnings are trimmed, these changes are immaterial to the long-term investment thesis, which remains anchored by recurring revenue growth, installed base expansion, and CORIS' medium-term potential. Our valuation and target price moderates to A$5.00 (from A$5.50) and we retain our BUY recommendation.
WiseTech Global Ltd (ASX: WTC)
Another ASX 300 share that could be destined to deliver big returns for investors over the next 12 months is logistics solutions software provider WiseTech Global.
Morgans recently put a buy rating and $127.60 price target on its shares. Based on its current share price of $96.11, this suggests that upside of 33% is possible between now and this time next year.
The broker remains very positive on the company and the recent game-changing acquisition of E2Open. And while it has trimmed its near term growth estimates slightly, this does little to its longer term outlook. It said:
WTC's FY25 result was broadly in line with expectations. While revenue was modestly lower than guidance, this was caught up by a 2H25 margin beat which saw WTC deliver underlying EBITDA growth of +27% (margins of 53%). FY26 EBITDA guidance for US$550-585m (+44-53% vs. FY25 reported EBITDA) was materially lower than consensus due largely to accounting treatment to align WTC/E2Open, however we do not see any fundamental change to the longer-term strategic value proposition associated with the acquisition. We reduce our EBITDA forecasts by -10%/-15% respectively in FY26-FY27F. Following these changes our DCF/EV/EBITDA based price target is revised to A$127.60/sh (from A$132.40/sh) and we retain our BUY rating.
